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Isolation and ampliﬁcation of primary lymphoma cells in vitro setting is technically and biologically challenging task. To optimize
culture environment and mimic in vivo conditions, lymphoma cell lines were used as a test case and were grown in 3-dimension
(3D) using a novel 3D tissue culture polystyrene scaﬀold with neonatal stromal cells to represent a lymphoma microenvironment.
In this model, the cell proliferation was enhanced more than 200-fold or 20,000% neoplastic surplus in 7 days when less than 1%
lymphoma cells were cocultured with 100-fold excess of neonatal stroma cells, representing 3.2-fold higher proliferative rate than
2D coculture model. The lymphoma cells grew and aggregated to form clusters during 3D coculture and did not maintained the
parental phenotype to grow in single-cell suspension. The cluster size was over 5-fold bigger in the 3D coculture by day 4 than
2D coculture system and contained less than 0.00001% of neonatal ﬁbroblast trace. This preliminary data indicate that novel 3D
scaﬀold geometry and coculturing environment can be customized to amplify primary cancer cells from blood or tissues related
to hematological cancer and subsequently used for personalized drug screening procedures.
1.Introduction
Emerging technologies in tissue engineering can be used to
create 3-dimensional (3D) diseased tissue or organ models
for screening therapeutic drugs and studying disease biology.
3D model is becoming more attractive to researchers as they
realized the shortcomings of traditional two-dimensional
(2D) in vitro tissue culture models. 2D culture does not
closely mimic in vivo environment and often overlooks
important variables such as dimensionality and microen-
vironment signaling [1, 2], which has an eﬀect on cancer
phenotype, aggressiveness, and drug resistance [3–10]. The
use of 3D scaﬀolds to engineer 3D solid tumor models has
been successful [11–15]. These in vitro 3D tumor models
showedtheirpotentialvaluesinoncologydrugscreeningand
tumor biology studies.
Previous works have demonstrated a direct link between
3D tumor microenvironment and cancer behavior. However,
a direct application of polymer-based tissue engineering
approach to recreate microenvironment for enrichment of
primary blood cancer cells has not been explored. From
the perspective of engineered cancer microenvironments,
the stroma is an ubiquitous and necessary component that
has been implicated during in vivo cancer progression [16–
19]. The stromal compartment can be found throughout
the body as a form of tissue support [20], covering inter-
nal conduits of secreting glands [21, 22], and increasing
surface contact during paracrine-mediated maturation of
cell populations in the bone marrow and lymphatic tissues
[23, 24]. Therefore, in vitro models that include 3D stroma
architecture oﬀer the most native representation of complex
cancer signatures during cancer progression.2 Journal of Tissue Engineering
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Figure 1: CAD models of 3D scaﬀolds. The scaﬀold is made of four layers (diﬀerent color represent diﬀerent layers from bottom to top) 90◦
and oﬀset with respect to each other. This geometry generates the characteristic 3D porous structure of the PS scaﬀold (a)–(c).
A part of personalized cancer treatment for hematolog-
ical malignancies requires culturing of primary cancer cells
from the patient and use the cells to identify drugs that are
most eﬀective in cell killing. However, patient specimens that
are derived from core biopsies, postoperative resection, and
peripheral blood typically generate an insuﬃcient number
of primary cancer cells for the purpose of screening drugs.
Consequently, identifying the “personalized” drugs for the
patient will not be practical and has been an extremely
diﬃcult task with conventional methods for cell culture.
The survival and the ampliﬁcation of primary cancer cells
are mainly due to suboptimum environment in vitro and
ineﬃcient 2-dimensional cell culture conditions. We have
investigated multiple 3-dimensional cell culture systems to
optimize the growth of cancer cells by using mantle cell
lymphoma cell lines.
H e m a t o l o g i c a lc a n c e r sa r em o r ec o m p l e xt h a ns o l i dc a n -
cers due to its ability to eﬃciently proliferate in suspension
and can proliferate or diﬀerentiate in stromal compartments
such as the bone marrow, lymph nodes, spleen, and thymus.
Lymphoma is a blood cancer type that involves both tissue
and lymph system and can progressively become worse when
cancer cells adapt to proliferate in the blood compartment.
Mantle cell lymphoma (MCL) is an aggressive B-cell type
lymphoma that represents up to 7% of all Non-Hodgkin’s
lymphomas in the USA and occurs more in older male
patients with a median age of 60 years [25]. MCL arises
from peripheral CD5-positive B-cells of the inner mantle
zone of secondary follicles and is diagnosed typically in
advanced stage (III/IV) to exhibit an aggressive B-cell lym-
phomacharacteristicthathasabroadmorphologicspectrum
[26]. Cytogenetic and immunohistochemical studies show
MCL to carry the hallmark chromosomal translocation,
t(11;14)(q13;q32) which causes overexpression of cyclinD1
and consequently implicates on disordered progression of
cell cycle [27]. To this date, MCL does not have standard
therapy for curative treatments but a combination of
Hyper-CVAD with Rituximab has shown promising clinical
outcomes as the front line therapy [28].
To treat MCL more eﬀe c t i v e l y ,a na m p l i ﬁ e dp r i m a r y
MCL cells derived from tissue or blood can be screened
with a short list of clinically available drugs, and the most
eﬀective drug or a combination of drugs can be considered
for the patient. In this report, MCL cell lines were used
to study conditions of 3-dimensional tumor microenviron-
ments mediated by stromal components in 3D polymer
scaﬀolds. The 3D coculture model presented here suggests
that MCL cells that still retain tumor microenvironment
phenotype may need to interact with stroma to unleash
their maximal growth potential. Thus, these ﬁndings may
help recreate true blood cancer phenotypes, minimizing the
burden to amplify primary MCL tumor cells from tissue
biopsies and surgical resections for high throughput drug
screening eﬀort.
2.MaterialsandMethods
2.1. Fabrication of 3D Polystyrene Polymer Scaﬀold. The 3D
12-well polystyrene (PS) scaﬀoldswereconstructedusing 3D
Precision Microfabrication system (3DPM) developed by 3D
Biotek (Figure 1). 3DPM generates porous 3D scaﬀolds from
polymers thermoplastic polymers with well-controlled pore
size and porosity. Each molten polystyrene ﬁber is laid down
with designated spacing on a ﬂat surface and the subsequent
layers are added at a 90◦ angle from the previous reference
layer.This3Dscaﬀoldshaveinterconnectedporousstructure
with uniform pore sizes and polymer ﬁbers. The 3D surface
area created by layering ﬁbers that are orthogonal to each
other increases in surface area, but every spatial point is still
close to each other. As opposed to the ﬂat surface with the
same surface area, the 3D scaﬀold keeps any two points in
close proximity. For example, the total surface area of the
3D insert with dimensions (diameter 2.2-cm and thickness
0.06-cm) is 21.08cm2, which is comparable to a 2D diskJournal of Tissue Engineering 3
with a 5.2-cm diameter. Thus, every two points in the 2D
disk will have a distribution of distances with a maximum
distance at 5.2cm, while in 3D for the same surface area the
distribution of distances will have a maximum distance of
2.2cm. For the cell culture experiment, the scaﬀold with a
ﬁber size of 300-um in diameter and a pore size of 400-um
diameter was used. To make these 3D scaﬀolds suitable for
suspension cell culture, polystyrene legs were introduced
to the 3D polystyrene scaﬀolds around the circumference
of the bottom of the scaﬀolds. These legs will raise the
scaﬀolds 0.5mm from the bottom surface of the cell culture
wells to minimize the contact with the underneath cell
culture well surface. After ﬁnishing the scaﬀold fabrication,
these scaﬀolds were plasma-treated using a Harrick Plasma
Cleaner (Model PDC-001, Ithaca, NY) and gamma-ray-
radiated before use.
2.2. Cell Lines. Two mantle cell lymphoma (MCL) cell
lines, HBL2 (derived from lymph node, CyclinD1+, CD5−,
CD23+) and Z138 (derived from bone marrow, CyclinD1+,
CD5−, CD23−), were cocultured with human dermal
ﬁbroblasts (hDFb) in this 3D coculture study. These cell lines
were chosen in this study because they are derived from
nonperipheral blood, proliferate eﬃciently and remain as
single cells suspensions in regular tissue culture conditions.
To prepare ﬁbroblast layer for coculture, hDFb were isolated
from human neonatal foreskins as described previously
[29]. The ﬁbroblast preparation at passage 4 was grown
in Gibco DMEM/F12 + GlutaMAX-I (Invitrogen, Carlsbad,
CA) media supplemented with 10% fetal calf serum (PAA,
Etobicoke Ontario, Canada) and 1% Penicillin/Streptomycin
(Cellgro, Herndon, VA). Stroma cells had a surface area of
1.5 × 10−5 cm2 and a doubling time of 2.5 days.
2.2.1. HBL2 and Z138 MCL Culture. For lymphoma cell
lines, HBL2 and Z138 mantle cell lymphoma cell lines
were grown in RPMI-1640 (with L-glutamine and NaHCO3,
Sigma St. Louis, MO) and supplemented with 10% fetal
bovine serum (PAA, Etobicoke Ontario, Canada) and 1%
Penicillin/Streptomycin. All cells were grown in water-
jacketedincubator(FormaScientiﬁc,Marietta,OH)with5%
CO2 and at 37◦C.
2.2.2. 3D and 2D Coculture. To determine the eﬀect of
dimensionality and presence of stroma (3D coculture
condition), a mixture of MCL and hDFb cells at the
ratios of 1,000:100,000 (0.9%), 10,000:100,000 (9.0%), or
50,000:100,000 (33%) was initially seeded at 200-μLi n
volume.Basedonthesurfaceareaofstromaandtheavailable
surface area of growth on 12-well 2D plates and 3D PS
scaﬀold, initial seeding was 37% in 2D and 7% in 3D PS
scaﬀolds. The surrounding empty wells of the 12-well plate
were ﬁlled with DPBS to maintain high humidity and avoid
volume loss of the initial mixture volume. After 3 hours
seeding, the plates were placed on an Adams Nutator (Model
1105,50–60Hz,BectonDickson,Parsippany,NJ)androcked
for12hoursinsidetheincubator.Thecellsweresubsequently
supplemented with 1.5-mL of conditioned medium that
was produced by coculturing hDFb and MCL cells at
50/50 ratio. For 2D-coculture, 200-uL of cell suspension at
the same MCL:hDFb ratios as 3D-coculture were added
1.5-mL of conditioned media and placed on the shaker
simultaneously with the 3D coculture plate. For routine
feeding, 66% media from each 12-well was removed and
changed for fresh coculture media (supplemented RPMI
1640 and DMEM/F12 + GlutaMAX-I) every 48 hours for 6
days.MCLcellaggregatesthatsettleatthebottomoftheplate
were collected at day 7 for quantiﬁcation and analysis.
2.3. Cell Proliferation and Viability. To harvest, cells were
collected from each well (12-well plates (2D) and 12-well
nontreated plates containing 3D PS scaﬀolds. 10-μLo fc e l l
suspension was mixed with 10-μL of 0.4% Tryphan Blue
dye (Sigma St. Louis, MO). Cells were counted using a
hemacytometer for each sample collected. Cells stained blue
were counted as nonviable. Based on initial lymphoma
seeding and current cell count after 7 days, the neoplastic
percent surplus was calculated following the equation: (Final
Cell Number/Initial Cell Number)∗100. This allowed us to
compare the proliferative capacity of the two MCL cell lines
under conditions of dimensionality and initial lymphoma
seeding percent. The data was graphed and processed using
Excel (Microsoft Excel Version 12.1.0) and Prism software
(GraphPad Software, Inc, Version 4.0c).
2.4. Lymphoma Cluster Analysis. During the course of the
experiment, pictures of the wells were taken at days 2
and 4 for 3D and 2D coculture of lymphoma and stroma
conditions. Clusters images were taken with an Insight
2Mp Monochrome Model 18.0 Camera attached to a
Nikon, Eclipse TS 100 inverted light microscope (Micron-
Optics, Cedar Knolls, NJ). Pictures were analyzed using Spot
Software (Diagnostic Instruments, Detroit, MI) and Image J
1.43u (N.I.H. USA) for cluster size and graphed using Prism
software (GraphPad Software, Inc, Version 4.0c).
2.5. Fibroblastic Contamination after Lymphoma Harvesting.
Collected lymphoma cells from 2D and 3D coculture condi-
tions were plated on treated T-75 ﬂaks and allowed to incu-
batefor24hoursunderregulartissuecultureconditions.The
next day, microscopic observation was made and pictures
were taken on the harvested lymphoma cells, particularly
looking for the presence of adherent dermal ﬁbroblast. We
took several pictures using an Insight 2Mp Monochrome
Model 18.0 Camera attached to a Nikon, Eclipse TS 100
inverted light microscope (Micron-Optics, Cedar Knolls,
NJ). Pictures were analyzed using Spot Software (Diagnostic
Instruments, Detroit, MI) and Image J to determine the pixel
density of adherent dermal ﬁbroblast after harvesting from
2D and 3D coculture. The data was tabulated and graphed
using Prism software.
3. Results
3.1. 3DPM-Based 3D Polystyrene Polymer Scaﬀold Provides
Excellent Structure Integrity for Cancer Tissue Engineering.4 Journal of Tissue Engineering
Three-dimensional polystyrene scaﬀolds with a 4-layer
porous structure were fabricated using 3DPM technology
(Figure 1). As shown in the CAD drawing of Figure 1,e a c h
layerofstrutsisrepresentedbyadiﬀerentcolorandthestruts
of each layer are layered in a 90-degree angle to its immediate
adjacent layer. Each ﬁber has a diameter of 300-um and
400-um ﬁber-to-ﬁber spacing. The strut-to-strut and layer-
to-layer spacing is optimized to provide both increased 3D
surface area and 3D space for cell attachment and growth.
For example, a four-layered scaﬀold provides with 16.4cm2
of the total surface area, which is 4-fold larger than the
growth surface area of a 12-well with a diameter of 2.1cm.
The scaﬀold was designed to raise the structure above the
bottomoftheplateandthisfeaturewasintendedtoprovidea
better ﬂow of medium and gas throughout the structure and
reduce medium volume losses during the ﬁrst 15 hours of
seeding the cell mixture. To construct this structural feature,
a polystyrene loop was generated at the edge of the scaﬀold
and polystyrene struts are laid orthogonal to form a mesh-
like structure (Figure 2). Figures 2(c) and 2(d) show the
second engineering feature that is represented by one side of
the scaﬀold projecting polystyrene loop (black arrow). This
loop allows the scaﬀold to be raised approximately 0.5mm
from the bottom of any surface, thus forming a rim around
the circumference of the scaﬀold which reduces contact with
the underneath surface. The scaﬀolds were plasma-treated
using a Harrick Plasma Machine (Model PDC-001, Ithaca,
NY) and gamma-radiated for sterility.
3.2. Coculturing of HBL-2 MCL and Stromal Cells in 3D
Environment Signiﬁcantly Enhances Growth of Lymphoma
Cells. In the absence of stroma cells, lymph-node-derived
HBL-2 cells grow mostly in single cell suspension by loosely
attaching to the polystyrene surface in both conventional
2D and 3D environment (Figure 3(a)). These cells expanded
in unidirection as they proliferate without stroma cells,
and the proliferation was independent of geometry because
3D culture did not show signiﬁcant advantages over con-
ventional 2D environment. Also, when seeded without
the stroma component, HBL-2 cells initially ﬂoated in
suspension within the interstitial space of the scaﬀold of the
3D environment (white arrows, Figure 3(a)) ,b u tm o s tc e l l s
gradually settled to the bottom of the well over time. In the
presenceofstromacells,thegrowthphenotypesofMCLcells
in both 2D and 3D environments changed remarkably after
coculturing with primary stromal cells that was generated
from human neonatal skin (Figures 3(c) and 3(d)). These
stroma cells (mostly ﬁbroblast) were found to attach equally
and ﬁrmly to both the 2D and 3D surfaces; the coculture
caused HBL-2 cells to adopt a stratiﬁed organization and
formed loosely aggregated cellular masses in both 2D and
3D cases. However, HBL-2 cells formed more clusters in
3D coculture model. Continued coculture produced large
masses of cell clusters that are predominantly HBL-2 cells
and the cluster formations were signiﬁcantly more active on
3D when compared with 2D environment (Figure 4). In the
3D coculture environment, HBL-2 lymphoma cells initially
adhered to stroma cells and start to form small aggregates.
These small aggregates continued to grow into larger clusters
within the porous structure of the 3D scaﬀolds. As the size
of these clusters reached a critical mass, all clusters became
separated from the stroma support and dropped eventually
the bottom of the well. When HBL-2 aggregates were
harvested from the 2D and 3D coculture models and placed
in suspension in the absence of stroma, they do not go back
to the morphology of single-cell suspension, suggesting that
interacting with primary stroma cells may have changed the
cellular programming of signaling pathways. In this setting,
the expression of previously reported 3D markers (Actin,
B2M, FMOD, TLR4, VTN, Collagen and Laminin and
Integrins (ITGA1, ITGA4, ITGAL, ITGAM, ITGB1, ITGB2))
f r o mv a r i o u s3 Ds p h e r o i dc u l t u r e sw e r et e s t e db yq R T - P C R
but no signiﬁcant diﬀerences were detected between HBL-
2 cells grown in 2D and 3D (see Supplementary Material
available online at doi: 10.1155/2011/362326).
3.3. HBL-2 Cells Proliferate with Greater Eﬃciency in 3D
Than 2D Coculture Environment. HBL-2 cells grown in 3D
with stroma cells had a signiﬁcantly higher eﬃciency in
generating cell clusters when compared with cells grown in
2D (Figure 4). At this seeding condition, HBL-2 clusters
were more than 2-fold larger in 3D than 2D within 2 days
and more than 10-fold larger by day 4. Three-dimensional
coculturing enhanced the proliferation of cancer cells and a
higher rate of clustering, as a result of faster dislodging of
clustersfromthestromasupport.Thus,acombinationofthe
geometry, greater surface area, and 3D spatial environment
provides signiﬁcantly better growth condition for MCL cells
derived from lymph node. The cluster size measurements in
this setting exclude continuously growing HBL-2 clusters on
the scaﬀold (Figure 4).
Tofurtherinvestigatetheoptimumgrowthcondition,the
seeding density of HBL-2 cells was tested at 0.9%, 9.0%, and
33% with respect to the number of cocultured stroma cells
(Table 1). After 7 days of coculture, the proliferation rate
of HBL-2 cells seeded in 0.9% category showed the fastest
growth followed by 9% and 33% categories (unpaired t-test
P = 0.001) in 3D than 2D (Figure 5). The cell viability
was 100% by day 7 and the cell division is calculated to
be 9.6 hours per division when the initial HBL-2 seeding
ration was 0.9%. At this condition, 3D coculture was able to
amplify 1,000 HBL-2 to 177,722 cells in a week, accounting
for a 17,722 ± 2,394% (STDEV) neoplastic surplus, which is
about 3.2-fold greater than HBL-2 proliferation in 2D cocul-
ture (Table 1). This suggested that the cell cycle of HBL-2
cells was remarkably enhanced by the direct interaction with
primary stroma in 3D compartments, mimicking the tumor
microenvironment. HBL-2 cells viability for the 3 seeding
conditions showed a decreasing trend with increasing HBL-
2 seeding ratio. The cell viability in 9% MCL condition
was 2-fold better than 33% MCL, but both cases failed to
show proliferation advantage on both 3D and 2D culture
conditions. We believe that the decreased proliferation and
cell viability was likely caused by the inability to supply
suﬃcient nutrients as a result of increased initial HBL-2
seeding density and its increased proliferation potential inJournal of Tissue Engineering 5
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Figure 2: 3D Polystyrene scaﬀold for 3D coculture model. Polystyrene ﬁbers are laid down at 90◦ angles with respect and oﬀset from each
other,creatingitscharacteristic3Dstructure.Thereisspacingbetweeneachﬁber(whitearrow)tocreatetheinterconnectedporousstructure
of the scaﬀold. The scaﬀold is made with ﬁbers 300-um in diameter and 400-um spacing between the ﬁbers (a, b). The scaﬀold also has a
loop around the rim of the scaﬀold. The loop is about 0.5-mm height (black arrows) allowing the scaﬀold to have a raised conformation
with reference to the bottom of the well (c, d).
3D/(−)stroma
(a)
2D/(−)stroma
(b)
3D/(+)stroma
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(d)
Figure 3: In vitro 3D and 2D MCL coculture models. HBL-2 lymphoma cells remain as single suspension cells (white arrows) in the absence
of stroma for 2D and 3D models (a, b). Mixtures of stroma and HBL-2 cells seeded on 3D PS scaﬀolds and 2D PS plate causes aggregation of
HBL-2. Over time, HBL-2 cells grow as weakly bound clusters on the surface of plates and from the internal ﬁbrous structure of the scaﬀold
(c, d). Scale-bar 250-μm.6 Journal of Tissue Engineering
Table 1: Proliferation of HBL-2 and Z138 on 3D and 2D stromal compartments.
Mantle cell lymphoma
0.90% HBL-2: stroma 0.90% Z138: stroma
Geometry 3D 2D 3D 2D
Day 0 1,000 1,000 1,000 1,000
Day 7 177,722 ± 23,940 55,777 ± 8,071 4,640 ± 1,282 2,260 ± 533
% surplus 17,722 5,577 464 226
% viability 100% 100% 100% 100%
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Figure 4: The eﬀect of 3D stroma on cluster size. After 2 days in
coculture, HBL-2 clusters from 3D stromal coculture were 0.25 ±
0.1 (STDEV) mm2 and HBL-2 clusters from 2D stromal coculture
0.1 ± 0.02 (STDEV) mm2. The diﬀerence in size became more
apparent at day 4, 3D stroma model yielded HBL-2 clusters with
an average size of 1.9 ± 0.7 (STDEV) mm2, approximately 10-
fold bigger than HBL-2 clusters from 2D stroma coculture at day
4( ±SEM in the graph) (n = 5).
the 3D coculture condition. When HBL-2 cells from 2D and
3D environments were analyzed for the cell proliferation
markers, it was found that the expressions of NFκBm e m b e r s
NFκB2, RELA, and RELB were overexpressed up to 2-fold in
3D setting (see Supplementary Material).
In order to further explore the eﬀe c to fs t r o m ao no t h e r
suspension MCL types, we investigated the proliferative
capacity of Z-138, a cell line derived from bone marrow, in
identical conditions as HBL-2 cell line (Figure 5). At day 7,
Z-138cellsshowedlowerproliferationwithapercentsurplus
of 464 ± 128% for 3D and 226 ± 53% for 2D and with no
clustering behavior, indicating that these cells may require
a speciﬁc bone marrow stroma-signaling signature. Despite
the lower proliferation rates, in comparison to HBL-2, Z-138
cells seeded at 0.9% in stroma had a higher percent surplus
in 3D than 2D at day 7. However, Z-138 in absence of stroma
wasnonviableforsameinitialcellseedingandtimeinculture
(Figure 5). These ﬁndings elucidate the synergy between
dimensionality and stroma microenvironment, particularly
its eﬀect on liquid cancer neoplastic growth.
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Figure 5: Neoplastic growth of HBL-2 on 3D and 2D stromal
models. HBL-2 eﬃciently proliferated at lower initial seeding
densities in 3D coculture with stroma. 0.9% HBL-2 mixture in
neonatal dermal ﬁbroblast showed statistically signiﬁcant greater
proliferation potential with a percent neoplastic surplus of 17,722
compared to 5,577 in 2D stroma. Increasing percent HBL-2 seeding
density did not show the same trend and cell viability was greatly
reduced (±SEM) (n = 4).
3.4. Three-Dimensional Coculture Eﬃciently Separates HBL-2
from MCL-Stroma Mixtures. Besides enhancement of HBL-
2 proliferation on 3D stromal compartments, we deter-
mined that harvesting of HBL-2 cells could be achieved
with minimal stroma contamination in the 3D coculture
condition. Figure 6 compares the eﬀect of geometry, that is,
2Dand3D,andHBL-2harvestingfromstromacellmixtures.
After 24 hours in static culture, HBL-2 remains as weakly
b o u n ds u s p e n s i o nc l u s t e r sf o rb o t h2 Da n d3 Dc u l t u r e
conditions (Figures 6(a) and 6(b)). However, there was a
marked diﬀerence in the amount of stroma cells adhering
to the bottom of the harvesting culture plates (Figures 6(c)
and 6(d)). In the 2D coculture condition, there was a large
number of stroma clusters (<10 clusters) and single adherent
stroma to the bottom of the culture dish. Quantiﬁcation of
the stromal contamination after harvesting shows that, at the
scale of single stroma cluster to single stroma cell, the gray
pixel value is 20-fold between the cell cluster to single cell
(Figures 6(e) and 6(f)). Thus, HBL-2 harvesting from 3D
coculture condition oﬀers both ampliﬁcation and eﬃcientJournal of Tissue Engineering 7
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Figure 6: Stroma traces after HBL-2 harvesting from 2D and 3D coculture. After harvesting, HBL-2 remained as single aggregates in
suspension and in the absence of stroma (a, b). There were traces of stroma from the 3D and 2D coculture systems adhering to the HBL-2
harvesting plates (c, d). Quantiﬁcation of stroma traces showed that there is a characteristic singe stroma to stroma clusters in 3D and 2D
coculture models, which is about 20-fold diﬀerence between single cell to single stroma cluster.
separation of MCL cells from heterogeneous cell mixtures at
minimal stroma contamination.
4. Discussion
Lymphoma cells reside and proliferate in environments
represented by tissue, bone marrow, and blood. In each
environment, lymphoma cells have adopted and utilize
unique survival signaling pathways that consequently com-
plicate cancer therapy options [30]. Among non-Hodgkin’s
lymphoma, mantle cell lymphoma (MCL) represents a
disease that is indolent yet aggressive in proliferative nature
that ultimately leads to unfavorable clinical outcome [31].
MCLcellscanalsometastasizefrombloodtomultipletissues8 Journal of Tissue Engineering
as they enter advance stages, and this systemic spread further
reducestargeted andpersonalized treatmentoptions [32].As
the disease advances to leukemic phase, drugs that may be
eﬀective for MCL cells in circulating blood may not be as
eﬀective when MCL cells are partly protected in the tumor
microenvironment in tissues. The proliferative potential and
molecular signatures of MCL cells are diﬀerent when the
cells in nutrient-rich blood environment are compared with
tumor environments that are localized to bone marrow or
lymphnodeswithstroma,inturnrequiringspeciﬁctargeting
strategies [33]. The neighboring stroma cells secrete various
growth factors to the local environment and directly support
and simultaneously protect MCL cells from anticancer drugs
[34–36]. To develop therapeutic options that is patient
speciﬁc and target MCL cells in tissues, primary MCL
cells must be initially grown and ampliﬁed in vitro cell
culture condition, so that the cells can be used for screening
a set of drugs that are currently available in the clinic.
However, this task is not practical due to low proliferative
potentialandviabilityofMCLcellsinconventional2Dtissue
culture conditions and the lack of appropriate 3D culture
environment that mimics the tumor microenvironment in
vivo. Selected factors such as soluble CD40 ligands or IL10
were exogenously added to amplify primary MCL cell in 2D
culture but the treatment promoted a limited cell growth
potential [37, 38]. We report that 3-dimensional tumor
microenvironment for MCL was successfully constructed
by using MCL cells with primary neonatal ﬁbroblast by
culturing the combination of cells in a polymer-derived 3D
scaﬀold. MCL cell lines derived from lymph node were used
as a model system to optimize 3D culture conditions that can
be implicated to amplify primary MCL cells from biopsies or
tissues that originate from surgical procedures in the clinic.
MCL cells that derived from lymph node (HBL-2)
proliferated with remarkable eﬃciency in the presence of
neighboring stroma cells when grown in 3DPM -based 3D
polystyrenepolymerscaﬀold.Inourexperimentalmodel,we
treated 2D and 3D equally in terms of volume of medium,
feeding schedule, the ratio of cell numbers/area and the
availability of surface area to grow for the total time in
culture. Particularly, the limitation of nutrition does not
represent a limiting factor that may diﬀerentiate the cell
proliferation between the two cases at 0.9% MCL: stroma
because this seeding density represent the optimum for the
12-well format and cell culture time of 7 days. The analyses
of previously reported markers from 3D spheroids on the
mixture of cells grown in 2D and 3D showed no diﬀerential
expressions of 3D markers involved in extracellular matrix,
cell adhesion, and cytoskeleton, further indicating that the
geometric eﬀect of 3D-stroma produced superior environ-
ment for the observed accelerated growth of lymphoma
cells. The cell doubling time of HBL-2 exceeded 3-fold in
the optimized 3D environment when compared to previous
reported doubling time in conventional 2D culture without
stroma [39]. Although HBL-2 cells grow in single cell
suspensioninconventional2D,thecellsintrinsicallyretained
signalingcircuitrythattakesanadvantageoftheneighboring
stroma cells to proliferate. The interaction of HBL-2 cells
and the supporting stroma cells was evident because they
actively grew together throughout the culturing phase and
until the cluster of HBL-2 cells began to separate apart from
thestroma.Theundeterminedfactorsthataresecretedbythe
neonatal stroma component may turn on genetic switches
in MCL cells to promote cell-to-cell interaction with the
stroma component to enhance the growth. Stroma cells were
previously used in cell culture for ex vivo expansion of cord
blood hematopoietic stem/progenitor cells [40] and long-
term culture and maintenance of leukemia or stem cells
[41, 42], suggesting the neonatal stroma contains suﬃcient
number of stem-like cells to supplement growth factors to
MCL cells in vitro [43, 44]. Recently, dermal cells isolated
from foreskin can diﬀerentiate into functional epidermal
melanocytes, indicating the presence of stem cell properties
in dermis-derived stroma components [45].
These reports and the data from our laboratory suggest
that the inclusion of the neonatal foreskin stroma in our
3D model plays a key role in the ampliﬁcation of MCL
cells. In our experimental setting, cell proliferation markers
from NFκB family were moderately increased in the mixture
of cells grown in 3D environment (see Supplementary
Material), suggesting that the proliferation potential of the
lymphoma cells (represented by <1% of total cell number in
the mixture) is superior in 3D scaﬀold condition than 2D.
Conversely, MCL cells derived from bone marrow (Z-138)
proliferated poorly albeit in the presence of neonatal stroma,
indicating that alternative factors may be needed to optimize
the growth. Nonetheless, the eﬀect of 3D stroma coculture
was able to maintain better growth and viability of Z-138
for low seeding density in the absence of dimensionality and
stroma. The results from HBL-2 and Z-138 diﬀerentiated the
requirements of optimal culturing conditions for MCL cells
that have dissimilar origins of tumor environment. Thus,
Z-138 many require a microenvironment that mimics bone
marrow and other supplementary factors besides neonatal
stroma. Furthermore, our preliminary data indicated that
MCL cell lines derived from peripheral blood, typically from
leukemic phases, may require yet another optimization of
culturing condition (data not shown). Our data suggest that
in order to better mimic diﬀerent types of tumor micro-
environment, such as blood, bone marrow, and lymphatic
tumors, diﬀerent types of stroma or supporting cells are
needed in the 3D scaﬀolds.
Patient specimens from surgical procedures normally
have a mixture of cancer cells with a great excess of stromal
cells. Tissue specimens of MCL from biopsies or surgical
resections (i.e., spleen) can be mixed and cultured in the
optimized 3D culture environment to selectively amplify
MCL cells away from the stroma. In this setting, an addition
of neonatal stroma may oﬀer necessary supplementary
factors to enhance the growth of MCL cells with minimal
stroma contamination. In our 3D model, HBL-2 cells
were ampliﬁed over 100-fold within 7 days period with
0.00001% contamination of stroma cells, indicating that
the stroma cells prefer to stay attached to the 3D scaﬀold
while MCL tumor cells undergo exponential growth phase
as in aggregates, in turn producing highly puriﬁed cancer
cell population. HBL-2 cells from the cluster did not go
back to the parental phenotype (single cell suspension)Journal of Tissue Engineering 9
when placed back in the 2D environment (data not shown),
indicating that the phenotype of single-cell suspension may
be directly associated with the absence of active stroma
cells. Several reports indicate that stromal cells in tumor
microenvironment play pivotal roles in B-cell malignancies
by activating multiple signaling pathways [46–48]. Together,
the combination of 3D system with polymer scaﬀold with
neonatal stroma provides an excellent growth environment
for the purpose of amplifying MCL cells, and similar 3D
environment can be implicated on other liquid and solid
tumor models. The model described here can improve
decision making on cancer treatment options by providing
a 3D cell-based platform to screen drugs that are currently in
clinical use and identifying best-ﬁt drug(s) for the patient.
We have shown the versatility of polymer-based scaﬀolds
fortherecreationofdimensionalityandcoculturesignatures.
Particularly, both contributions have biological relevance,
seen as a superior proliferation of HBL-2 and maintenance
of Z138 under the prescribed conditions. Further work
is necessary to explore the versatility of the model using
primary cell mixtures. This would increase the attractiveness
of 3D polymer scaﬀolds for the recreation of personalized
cancersignaturesandeﬀectivedrugscreeningmethodologies
in cancer therapies.
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